Lloyd-Still J D, Beno D W, Kimura R M
Rush Medical College, Department of Gastroenterology and Nutrition, Rush Presbyterian-St. Lukes Medical Center, 1725 Harrison Street, Chicago, IL 60612, USA.
Curr Gastroenterol Rep. 1999 Jun;1(3):231-7. doi: 10.1007/s11894-999-0040-4.
An epidemic of fibrosing colonopathy, a new disease caused by the prolonged administration of excessive doses of pancreatic enzymes, was first reported in 1994. More than 60 cases were known to occur worldwide before dosage guidelines were enforced. Predisposing factors were young age, previous intestinal surgery, meconium ileus equivalent, and use of H2 blockers, corticosteroids, and DNase. Abnormal features included foreshortened colon, strictures, marked submucosal fibrosis, ascites, and nodular hyperplasia of the liver. Histologic examination showed eosinophilia, mild cryptitis, epithelial regeneration, and widespread interruption of the muscularis mucosa. These findings are distinct from, but share many of the features of, those of Crohn's's disease and ischemic bowel disease. The pathogenic mechanisms remain unknown.
纤维性结肠病是一种因长期过量服用胰酶所致的新疾病,1994年首次报道了该病的流行情况。在实施剂量指南之前,全球已知有60多例病例。易感因素包括年轻、既往肠道手术史、胎粪性肠梗阻等效症以及使用H2阻滞剂、皮质类固醇和脱氧核糖核酸酶。异常特征包括结肠缩短、狭窄、明显的黏膜下纤维化、腹水和肝脏结节性增生。组织学检查显示嗜酸性粒细胞增多、轻度隐窝炎、上皮再生以及肌层黏膜广泛中断。这些发现与克罗恩病和缺血性肠病不同,但有许多共同特征。其致病机制尚不清楚。